top of page
BPIQ Blog

Oct 28, 20221 min read
Biopharma Pulse - 10/24-10/28 Week in Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
Oct 25, 20223 min read
Exciting conferences in Kidney, Liver, and Alzheimer's disease! - 2022 Investor Hub
Posted 10/25/22; updated 10/27/22 Summary Multiple exciting conference are taking place over the next two months! ASN Kidney Week takes...
Oct 24, 20223 min read
The American Society of Hematology Annual Meeting 2022 - Investor Hub
Published 10/24/22; updated 11/3/22 Summary The 64th annual American Society of Hematology meeting takes place from December 10-13, 2022...

Oct 21, 20221 min read
Biopharma Pulse - 10/17-10/21 Week in Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Oct 14, 20221 min read
Biopharma Pulse - 10/10-10/14 Week in Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
Oct 12, 20222 min read
Which smid-cap biopharmas are presenting exciting data at SITC 2022?
Summary: The Society for Immunotherapy of Cancer (SITC) annual conference takes place November 8-12, 2022 SITC abstract titles were...

Oct 7, 20221 min read
Biopharma Pulse - 10/3-10/7 Week in Review
Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
Oct 7, 20221 min read
Third Quarter Returns - How did Biopharma measure up?
Summary: Biotech companies outperformed other indices in third quarter returns! This was especially seen in smid-cap biopharmas We follow...
Oct 6, 20221 min read
Exciting Medical Meetings in 2023!
Summary: Many exciting medical meetings are planned throughout 2023 Multiple cancer meetings are expected as well as meetings in liver,...

Sep 30, 20222 min read
BCRX - Bull Thesis (DUPLICATE _ DO NOT PUBLISH)
BCRX is a commercial stage company that focuses on difficult to develop oral therapies for rare disease with a productive drug...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page